Scientists generate world’s first ’extraordinary aromatic tomato plants’ by simultaneously altering two key genes ...

How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

Americans love science and revere innovation, almost as a rule, and politicians of every stripe have spent the better part of a century promoting and protecting both. However imperfect the resulting ...

The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.

Equity Insider News Commentary, The immuno-oncology market is forecast to grow from $65.22 billion in 2025 to $170.19 billion by 2032, fueled by checkpoint inhibitors, CAR-T cell therapy, and cancer ...

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.

Through an AI-enabled platform, the partnership between two non-profit groups seeks to bring overlooked cell and gene ...